Table 4.
PTSD | No-PTSD CG | Analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | Mean | SD | CImean | Median | Mean | SD | CImean | p | d | CId | |
Drug therapies | |||||||||||
2 years pre | 0 | 57 | 243 | 53–62 | 0 | 9 | 86 | 9–10 | * | 0.36 | 0.34–0.38 |
1 year pre | 0 | 71 | 244 | 67–75 | 0 | 10 | 82 | 9–10 | * | 0.47 | 0.45–0.49 |
Index year | 10 | 119 | 315 | 114–125 | 0 | 10 | 82 | 9–11 | * | 0.69 | 0.67–0.71 |
1 year post | 0 | 105 | 309 | 100–110 | 0 | 10 | 79 | 10–11 | * | 0.61 | 0.59–0.63 |
2 years post | 0 | 95 | 279 | 90–100 | 0 | 11 | 78 | 10–11 | * | 0.59 | 0.57–0.61 |
Total | 51 | 447 | 1154 | 427–467 | 0 | 50 | 348 | 47–53 | * | 0.66 | 0.64–0.68 |
Outpatient treatments | |||||||||||
2 years pre | 97 | 354 | 751 | 341–367 | 0 | 91 | 321 | 89–94 | * | 0.59 | 0.57–0.61 |
1 year pre | 205 | 501 | 790 | 487–515 | 0 | 101 | 348 | 98–104 | * | 0.85 | 0.83–0.87 |
Index year | 767 | 1164 | 1115 | 1145–1184 | 0 | 109 | 367 | 106–112 | * | 1.77 | 1.75–1.79 |
1 year post | 449 | 912 | 1179 | 892–932 | 0 | 117 | 377 | 114–120 | * | 1.27 | 1.25–1.29 |
2 years post | 335 | 739 | 1074 | 720–757 | 0 | 128 | 408 | 124–131 | * | 1.01 | 0.99–1.03 |
Total | 2682 | 3670 | 3522 | 3609–3730 | 67 | 546 | 1382 | 534–558 | * | 1.56 | 1.54–1.58 |
Inpatient treatments | |||||||||||
2 years pre | 0 | 655 | 5504 | 560–750 | 0 | 55 | 853 | 47–62 | * | 0.23 | 0.21–0.25 |
1 year pre | 0 | 983 | 4353 | 908–1058 | 0 | 76 | 1537 | 63–89 | * | 0.38 | 0.36–0.40 |
Index year | 0 | 2727 | 7282 | 2601–2853 | 0 | 78 | 1016 | 69–87 | * | 0.78 | 0.76–0.80 |
1 year post | 0 | 1188 | 5193 | 1098–1278 | 0 | 109 | 1780 | 93–124 | * | 0.38 | 0.37–0.40 |
2 years post | 0 | 1009 | 4860 | 925–1093 | 0 | 114 | 1,635 | 100–128 | * | 0.34 | 0.32–0.36 |
Total | 0 | 6562 | 16,712 | 6274–6851 | 0 | 431 | 3737 | 399–463 | * | 0.75 | 0.73–0.77 |
Sickness benefit payments | |||||||||||
2 years pre | 0 | 144 | 1188 | 123–164 | 0 | 26 | 494 | 22–31 | * | 0.17 | 0.15–0.19 |
1 year pre | 0 | 311 | 1774 | 280–341 | 0 | 30 | 546 | 25–35 | * | 0.30 | 0.28–0.32 |
Index year | 0 | 960 | 3297 | 903–1017 | 0 | 34 | 590 | 29–39 | * | 0.59 | 0.57–0.61 |
1 year post | 0 | 355 | 1850 | 323–387 | 0 | 45 | 770 | 38–52 | * | 0.29 | 0.27–0.31 |
2 years post | 0 | 242 | 1706 | 213–272 | 0 | 54 | 781 | 48–61 | * | 0.18 | 0.16–0.20 |
Total | 0 | 2011 | 5796 | 1911–2111 | 0 | 190 | 1773 | 175–206 | * | 0.60 | 0.58–0.62 |
Losses of gross value | |||||||||||
2 years pre | 0 | 1165 | 5988 | 1062–1268 | 0 | 210 | 2326 | 190–230 | * | 0.28 | 0.26–0.30 |
1 year pre | 0 | 2233 | 8627 | 2084–2382 | 0 | 234 | 2494 | 213–256 | * | 0.45 | 0.43–0.47 |
Index year | 0 | 5281 | 14,021 | 5039–5523 | 0 | 265 | 2736 | 242–289 | * | 0.75 | 0.73–0.77 |
1 year post | 0 | 2222 | 8703 | 2071–2372 | 0 | 306 | 3068 | 279–332 | * | 0.40 | 0.38–0.42 |
2 years post | 0 | 1624 | 7531 | 1494–1754 | 0 | 392 | 3497 | 361–422 | * | 0.27 | 0.25–0.29 |
Total | 0 | 12,524 | 28,597 | 12,031–13,018 | 0 | 1,407 | 8479 | 1334–1480 | * | 0.75 | 0.73–0.77 |
Total costs | |||||||||||
2 years pre | 127 | 2374 | 9620 | 2208–2540 | 0 | 392 | 3119 | 365–419 | * | 0.39 | 0.37–0.41 |
1 year pre | 317 | 4099 | 12,064 | 3890–4307 | 0 | 451 | 3577 | 420–481 | * | 0.58 | 0.56–0.60 |
Index year | 2029 | 10,251 | 20,057 | 9905–10,597 | 0 | 496 | 3722 | 464–528 | * | 1.02 | 1.00–1.04 |
1 year post | 760 | 4782 | 12,502 | 4566–4998 | 0 | 587 | 4447 | 549–625 | * | 0.61 | 0.59–0.63 |
2 years post | 509 | 3709 | 11,105 | 3517–3901 | 0 | 698 | 4850 | 657–740 | * | 0.46 | 0.44–0.48 |
Total | 7505 | 25,215 | 41,341 | 24,501–25,929 | 82 | 2624 | 11,916 | 2521–2727 | * | 1.06 | 1.04–1.08 |
Costs are expressed in euros (EUR)
CI 95% confidence intervals
*Significant test results for Student’s t test after Bonferroni-correction (p < 0.001/36 = 0.000027)